"Immunization" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow).
| Descriptor ID |
D007114
|
| MeSH Number(s) |
E02.095.465.425.400 E05.478.550 N02.421.726.758.310 N06.850.780.200.425 N06.850.780.680.310
|
| Concept/Terms |
Immunization- Immunization
- Immunizations
- Sensitization, Immunologic
- Sensitization, Immunological
- Immunological Sensitization
- Immunological Sensitizations
- Sensitizations, Immunological
- Immunologic Stimulation
- Immunostimulation
- Immunological Stimulation
- Immunological Stimulations
- Stimulation, Immunological
- Stimulations, Immunological
- Immunologic Sensitization
- Stimulation, Immunologic
|
Below are MeSH descriptors whose meaning is more general than "Immunization".
Below are MeSH descriptors whose meaning is more specific than "Immunization".
This graph shows the total number of publications written about "Immunization" by people in this website by year, and whether "Immunization" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1998 | 2 | 0 | 2 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 2 | 0 | 2 |
| 2004 | 1 | 1 | 2 |
| 2006 | 2 | 0 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 3 | 2 | 5 |
| 2012 | 4 | 0 | 4 |
| 2013 | 2 | 0 | 2 |
| 2015 | 3 | 0 | 3 |
| 2016 | 2 | 1 | 3 |
| 2017 | 1 | 2 | 3 |
| 2019 | 2 | 0 | 2 |
| 2020 | 0 | 2 | 2 |
| 2021 | 5 | 4 | 9 |
| 2022 | 0 | 3 | 3 |
| 2023 | 0 | 4 | 4 |
| 2024 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunization" by people in Profiles.
-
Vaccination Timeliness Among US Children Aged 0-19 Months, National Immunization Survey-Child 2011-2021. JAMA Netw Open. 2024 Apr 01; 7(4):e246440.
-
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2024. MMWR Morb Mortal Wkly Rep. 2024 Jan 11; 73(1):6-10.
-
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States, 2024. MMWR Morb Mortal Wkly Rep. 2024 Jan 11; 73(1):11-15.
-
Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged =6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2023. MMWR Morb Mortal Wkly Rep. 2023 Oct 20; 72(42):1140-1146.
-
Inequities in COVID-19 vaccination coverage for adolescents with and without disability, national immunization Survey-Child COVID module, July 22, 2021-February 26, 2022. Disabil Health J. 2023 10; 16(4):101509.
-
A Learning Health System Approach to Increasing Human Papillomavirus Immunizations Among Young Adults. Perm J. 2023 06 15; 27(2):31-36.
-
All Older Adults Benefit From Pneumococcal Vaccinations-The Case for Evaluating Vaccine Effectiveness Using All-Cause Pneumonia. JAMA Intern Med. 2023 01 01; 183(1):48-49.
-
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022. MMWR Morb Mortal Wkly Rep. 2022 Nov 11; 71(45):1436-1441.
-
Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged =18 years - United States, July 2022. MMWR Morb Mortal Wkly Rep. 2022 Aug 05; 71(31):988-992.
-
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022. MMWR Morb Mortal Wkly Rep. 2022 Jul 01; 71(26):859-868.